Literature DB >> 18515105

Effectiveness and reliability of sentinel lymph node biopsy under local anesthesia for breast cancer.

Youwanush Kongdan1, Prakasit Chirappapha, Panuwat Lertsithichai.   

Abstract

The objective of the present study was to determine the effectiveness and reliability of sentinel lymph node biopsy (SLNB) performed under local anesthesia (LA) for patients with breast cancer, by comparing the results with those obtained under general anesthesia (GA). Between January 2006 and February 2007, SLNB was performed under LA or GA in 37 and 94 patients with clinical Tis, T1, T2 or T3 N0 breast cancer, respectively. All underwent radiocolloid and blue dye injections to identify sentinel nodes. The sentinel node detection rate, the number of nodes harvested and the number of positive nodes were compared between the two groups. The sentinel node identification rates were similar for both groups. The number of sentinel and axillary nodes removed and number of positive nodes did not differ significantly between the two groups. SLNB performed under LA is an effective and reliable alternative to SLNB done under GA.

Entities:  

Mesh:

Year:  2008        PMID: 18515105     DOI: 10.1016/j.breast.2008.04.003

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  2 in total

Review 1.  Sentinel lymph node biopsy under local anesthesia in patients with breast cancer.

Authors:  Prakasit Chirappapha; Visnu Lohsiriwat; Youwanush Kongdan; Panuwat Lertsithichai; Thongchai Sukarayothin; Chairat Supsamutchai; Nina Talakhadze; Stefano Zurrida
Journal:  Gland Surg       Date:  2012-11

2.  Salivary cortisol levels and anxiety in melanoma patients undergoing sentinel lymph node excision under local anesthesia versus general anesthesia: a prospective study.

Authors:  Philipp Jansen; Ingo Stoffels; Anne-Christine Müseler; Maximilian Petri; Titus J Brinker; Manfred Schedlowski; Dirk Schadendorf; Harald Engler; Joachim Klode
Journal:  World J Surg Oncol       Date:  2020-03-10       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.